Novel prodrugs for targeting diagnostic and therapeutic radionuclides to solid tumors

Molecules

Volumn 13, Issue 2, 2008, Pages 391-404

  Kassis, Amin I ^a   Korideck, Houari ^a   Wang, Ketai ^a   Pospisil, Pavel ^a   Adelstein, S James ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Prodrug; Radioimaging; Radioiodine; Radiotherapy; Solid tumors

Indexed keywords

DIAGNOSTIC AGENT; PRODRUG; RADIOISOTOPE;

ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; NEOPLASM; REVIEW; SCINTISCANNING;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; NEOPLASMS; PRODRUGS; RADIOISOTOPES;

EID: 40349084085     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules13020391     Document Type: Review

References (37)

1. Kassis, A.I.; Harapanhalli, R.S. Methods for enzyme-mediated tumor diagnosis and therapy. U.S. Patent Pending, 2001; application no. 2001-839779.
2. Ho, N.; Harapanhalli, R.S.; Dahman, B.A.; Chen, K.; Wang, K.; Adelstein, S.J.; Kassis, A.I. Synthesis and biologic evaluation of a radioiodinated quinazolinone derivative for enzyme-mediated insolubilization therapy. Bioconj. Chem. 2002, 13, 357-364.
3. Chen, K.; Wang, K.; Kirichian, A.M.; Al Aowad, A.F.; Iyer, L.K.; Adelstein, S.J.; Kassis, A.I. In silico design, synthesis, and biological evaluation of radioiodinated quinazolinone derivatives for alkaline phosphatase-mediated cancer diagnosis and therapy. Mol. Cancer Ther. 2006, 5, 3001-3013.
4. Pospisil, P.; Iyer, L.K.; Adelstein, S.J.; Kassis, A.I. A combined approach to data mining of textual and structured data to identify cancer-related targets. BMC Bioinformatics 2006, 7, 354.
5. Chen, K.; Al Aowad, A.F.; Adelstein, S.J.; Kassis, A.I. Molecular-docking-guided design, synthesis, and biologic evaluation of radioiodinated quinazolinone prodrugs. J. Med. Chem. 2007, 50, 663-673.
6. Pospisil, P.; Wang, K.; Al Aowad, A.F.; Iyer, L.K.; Adelstein, S.J.; Kassis, A.I. Computational modeling and experimental evaluation of a novel prodrug for targeting the extracellular space of prostate tumors. Cancer Res. 2007, 67, 2197-2205.
7. Wang, K.; Kirichian, A.M.; Al Aowad, A.F.; Adelstein, S.J.; Kassis, A.I. Evaluation of chemical, physical, and biologic properties of tumor-targeting radioiodinated quinazolinone derivative. Bioconjugate Chem. 2007, 18, 754-764.
8. Kassis, A.I. Compounds and methods for enzyme-mediated tumor imaging and therapy. U.S. provisional patent pending, 2007.
9. Kassis, A.I. Radiotargeting agents for cancer therapy. Expert Opin. Drug Deliv. 2005, 2, 981-991.
10. Blaschke, C.; Yeh, A.; Camon, E.; Colosimo, M.; Apweiler, R.; Hirschman, L.; Valencia, A. Do you do text? Bioinformatics 2005, 21, 4199-4200.
11. NCBI PubMed, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi.
12. UniProt, the Universal Protein Resource, http://www.pir.uniprot.org/.
13. NCBI Entrez Gene (supercedes LocusLink), http://www.ncbi.nlm.nih.gov/ projects/LocusLink/.
14. IT.Omics LSGraph®, http://lsgraph.it-omics.com/.
15. Ingenuity® Systems, http://www.ingenuity.com/products/ pathways_analysis.html.
16. 123I-labelled monoclonal antibody (NDOG2) directed against placental alkaline phosphatase. Br. J. Obstet. Gynaecol. 1985, 92, 277-286.
17. 123I-labelled monoclonal antibody (H317) specific for placental-type alkaline phosphatase. Clin. Radiol. 1986, 37, 107-112.
18. Stigbrand, T.; Hietala, S.-O.; Johansson, B.; Makiya, R.; Riklund, K.; Ekelund, L. Tumour radioimmunolocalization in nude mice by use of antiplacental alkaline phosphatase monoclonal antibodies. Tumor Biol. 1989, 10, 243-251.
19. Kosmas, C.; Kalofonos, H.P.; Hird, V.; Epenetos, A.A. Monoclonal antibody targeting of ovarian carcinoma. Oncology 1998, 55, 435-446.
20. Le Du, M.H.; Stigbrand, T.; Taussig, M.J.; Ménez, A.; Stura, E.A. Crystal structure of alkaline phosphatase from human placenta at 1.8 Å resolution: implication for a substrate specificity. J. Biol. Chem. 2001, 276, 9158-9165.
21. Ho, D.H.W. Distribution of kinase and deaminase of 1-β-D- arabinofuranosylcytosine in tissues of man and mouse. Cancer Res. 1973, 33, 2816-2820.
22. Ortlund, E.; LaCount, M.W.; Lebioda, L. Crystal structures of human prostatic acid phosphatase in complex with a phosphate ion and α-benzylaminobenzylphosphonic acid update the mechanistic picture and offer new insights into inhibitor design. Biochemistry (Mosc) 2003, 42, 383-389.
23. Schneider, G.; Lindqvist, Y.; Vihko, P. Three-dimensional structure of rat acid phosphatase. EMBO J. 1993, 12, 2609-2615.
24. Porvari, K.S.; Herrala, A.M.; Kurkela, R.M.; Taavitsainen, P.A.; Lindqvist, Y.; Schneider, G.; Vihko, P.T. Site-directed mutagenesis of prostatic acid phosphatase: catalytically important aspartic acid 258, substrate specificity, and oligomerization. J. Biol. Chem. 1994, 269, 22642-22646.
25. Lindqvist, Y.; Schneider, G.; Vihko, P. Crystal structures of rat acid phosphatase complexed with the transition-state analogs vanadate and molybdate: implications for the reaction mechanism. Eur. J. Biochem. 1994, 221, 139-142.
26. 31P nuclear magnetic resonance spectroscopy. Cancer Res. 1992, 52, 1259-1266.
27. 31P magnetic resonance spectroscopy. Biochem. Pharmacol. 1999, 57, 309-312.
28. 31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate. Am. J. Physiol. 1994, 267, C195-C203.
29. Timperley, W.R. Alkaline-phosphatase-secreting tumour of lung. Lancet 1968, 2, 356.
30. Suzuki, H.; Iino, S.; Endo, Y.; Torii, M.; Miki, K.; Oda, T. Tumor-specific alkaline phosphatase in hepatoma. Ann. N. Y. Acad. Sci. 1975, 259, 307-320.
31. Higashino, K.; Kudo, S.; Ohtani, R.; Yamamura, Y. Further observation on Kasahara isoenzyme in patients with malignant diseases. Gann 1976, 67, 909-911.
32. Benham, F.J.; Povey, M.S.; Harris, H. Placental-like alkaline phosphatase in malignant and benign ovarian tumors. Clin. Chim. Acta 1978, 86, 201-215.
33. Nadji, M.; Tabei, Z.; Castro, A.; Morales, A.R. Immunohistological demonstration of prostatic origin of malignant neoplasms. Lancet 1979, 1, 671-672.
34. Loor, R.; Wang, M.C.; Valenzuela, L.; Chu, T.M. Expression of prostatic acid phosphatase in human prostate cancer. Cancer Lett. 1981, 14, 63-69.
35. Wick, M.R.; Swanson, P.E.; Manivel, J.C. Placental-like alkaline phosphatase reactivity in human tumors: an immunohistochemical study of 520 cases. Hum. Pathol. 1987, 18, 946-954.
36. Azumi, N.; Traweek, S.T.; Battifora, H. Prostatic acid phosphatase in carcinoid tumors: immunohistochemical and immunoblot studies. Am. J. Surg. Pathol. 1991, 15, 785-790.
37. Dabare, A.A.N.P.M.; Nouri, A.M.E.; Cannell, H.; Moss, T.; Nigam, A.K.; Oliver, R.T.D. Profile of placental alkaline phosphatase expression in human malignancies: effect of tumour cell activation on alkaline phosphatase expression. Urol. Int. 1999, 63, 168-174.